Revefenacin-d9
Revefenacin-d9 (TD-4208-d9) is deuterium labeled Revefenacin. Revefenacin (TD-4208; GSK1160724) is a potent mAChR antagonist; has a high affinity on M3 receptor with a Ki of 0.18 nM.
Product Specifications
Product Name Alternative
TD-4208-d9; GSK1160724-d9
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Smiles
O=C(OC1CCN(CCN(C(C2=CC=C(CN3C([2H])([2H])C([2H])([2H])C(C(N)=O)([2H])C([2H])([2H])C3([2H])[2H])C=C2)=O)C)CC1)NC4=CC=CC=C4C5=CC=CC=C5
Molecular Formula
C35H34D9N5O4
Molecular Weight
606.80
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
A110-236B 0.5 mg
Goat anti-Rat IgG-Fc Fragment Cross-Adsorbed Antibody Biotinylated
Ask
View Details 